Trial Profile
Open-label Study Investigating the Excretion Balance, Pharmacokinetics and Metabolism of a Single Oral Dose of [14C]-Labeled RO7034067 in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Oct 2018
Price :
$35
*
At a glance
- Drugs Risdiplam (Primary)
- Indications Spinal muscular atrophy
- Focus Pharmacokinetics
- Sponsors Roche
- 16 Mar 2017 Status changed from recruiting to completed.
- 01 Feb 2017 New trial record